產(chǎn)品搜索
相關(guān)文章
- PD-1阻斷療法激活的T細(xì)胞還需依賴CD28共刺激
- 一個(gè)好的ATCC細(xì)胞株有多方面要求
- 【連載-企業(yè)參考品】 前列腺癌的診斷參考品的選擇
- 有關(guān)腫瘤細(xì)胞的基因突變研究講解
- ATCC細(xì)胞的貼壁過(guò)程有何特點(diǎn)呢?
- IL2細(xì)胞篩選模型
- 【靶點(diǎn)模型+診斷質(zhì)控】BCR-ABL1的藥物開(kāi)發(fā)和診斷
- *針對(duì)肝癌的PD-1抗體獲FDA批準(zhǔn),國(guó)產(chǎn)PD-1抗體進(jìn)入三期
- Cell Metab:雙信號(hào)通路失調(diào)協(xié)同促進(jìn)肺癌形成
- 【連載-企業(yè)參考品】胃癌的診斷參考品的選擇
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73283c-Kit W557_K558del-V654A/BaF3
- 詳細(xì)內(nèi)容
CBP73283 | |
| I. Introduction | |
Cell Line Name: | c-Kit W557_K558del-V654A/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
KIT W557_K558del results in the deletion of 2 amino acids in the juxtamembrane domain (exon 11) of the Kit protein from amino acids 557 to 558 (PMID: 12918066). W557_K558del results in constitutive activation of Kit and increased Erk phosphorylation, and leads to increased invasiveness and expression of ETV1 in cell culture (PMID: 25239608, PMID: 26936919). | |
| III. Representative Data | |
1.WB of c-Kit W557_K558del-V654A/BaF3
| |
2.Sanger of c-Kit W557_K558del-V654A/BaF3
Figure 2. c-Kit W557_K558del-V654A/BaF3 V654A
Figure 3. c-Kit W557_K558del-V654A/BaF3 W557_K558del | |
3. Anti-proliferation assay
Figure 4. CTG Proliferation Assay of BaF3 C-KIT W557_ K558del/V654A(C8). | |
| |








會(huì)員_a.png)